✦ LIBER ✦

Lack of Effect of Nizatidine-Induced Elevation of Gastric pH on the Oral Bioavailability of Dapsone in Healthy Volunteers

✍ Scribed by Dr. Gail S. Itokazu; Dr. James H. Fischer; Dr. Prasarn Manitpisitkul; Dr. Radhika Hariharan; Dr. Larry H. Danziger

Book ID: 115048481
Publisher: John Wiley and Sons
Year: 2002
Tongue: English
Weight: 46 KB
Volume: 22
Category: Article
ISSN: 0277-0008
DOI: 10.1592/phco.22.16.1426.33695

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of Ensure on the Oral Bioavailabi

Effect of Ensure on the Oral Bioavailability of Gatifloxacin in Healthy Volunteers

✍ Michael B. Kays; Brian R. Overholser; Seema Lagvankar; Mitchell Goldman; Kevin M 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

Effect of gastric pH on the relative ora

Effect of gastric pH on the relative oral bioavailability and pharmacokinetics of temozolomide

✍ Philip Beale; Ian Judson; Sally Moore; Paul Statkevich; Aliceanne Marco; David L 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 127 KB

Effect of Food and Ranitidine on Saquina

Effect of Food and Ranitidine on Saquinavir Pharmacokinetics and Gastric pH in Healthy Volunteers

✍ Thomas N. Kakuda; Ronald W. Falcon 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB

Effect of Gastric pH on the Bioavailabil

Effect of Gastric pH on the Bioavailability of Albendazole in Rabbits

✍ N. KOHRI; Y. YAMAYOSHI; K. ISEKI; N. SATO; S. TODO; K. MIYAZAKI 📂 Article 📅 1998 🏛 Pharmaceutical Press 🌐 English ⚖ 347 KB

Comparison of the effects of oral nizati

Comparison of the effects of oral nizatidine and ranitidine on gastric volume and pH in patients undergoing gynaecological laparoscopy

✍ M. T. POPAT; O. J. DYAR; C. E. BLOGG 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 449 KB

Complete bioavailability and lack of foo

Complete bioavailability and lack of food-effect on pharmacokinetics of gliclazide 30 mg modified release in healthy volunteers

✍ P. Delrat; M. Paraire; R. Jochemsen 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

## Abstract A new modified release (MR) formulation containing 30 mg of gliclazide was developed to obtain a better predictable release of the active principle and to allow once‐daily dosing regimen. An absolute bioavailability study was carried out to characterise the performance of the new formul